|
LBR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.320000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.986950E-01 |
| Normal-vs-Stage2 |
2.853400E-01 |
| Normal-vs-Stage3 |
4.370200E-02 |
| Normal-vs-Stage4 |
8.056300E-02 |
| Stage1-vs-Stage2 |
7.615400E-01 |
| Stage1-vs-Stage3 |
2.471400E-01 |
| Stage1-vs-Stage4 |
4.123800E-01 |
| Stage2-vs-Stage3 |
7.314400E-01 |
| Stage2-vs-Stage4 |
8.303000E-01 |
| Stage3-vs-Stage4 |
8.581800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.011810E-01 |
| Normal-vs-AfricanAmerican |
2.864200E-02 |
| Normal-vs-Asian |
4.620600E-01 |
| Caucasian-vs-AfricanAmerican |
2.896400E-01 |
| Caucasian-vs-Asian |
1.863250E-01 |
| AfricanAmerican-vs-Asian |
5.305500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.138240E-01 |
| Normal-vs-Female |
8.041600E-02 |
| Male-vs-Female |
8.539800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.483400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.531600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.940000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.866500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.477800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.119000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.592000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.393200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.381380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.900800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.024800E-01 |
| Normal-vs-Grade 2 |
5.598800E-01 |
| Normal-vs-Grade 3 |
1.972350E-02 |
| Normal-vs-Grade 4 |
1.045570E-02 |
| Grade 1-vs-Grade 2 |
6.915800E-01 |
| Grade 1-vs-Grade 3 |
1.729800E-01 |
| Grade 1-vs-Grade 4 |
1.050240E-01 |
| Grade 2-vs-Grade 3 |
3.720200E-02 |
| Grade 2-vs-Grade 4 |
2.285800E-02 |
| Grade 3-vs-Grade 4 |
2.670200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.272800E-01 |
| Normal-vs-ccB subtype |
6.718400E-02 |
| ccA subtype-vs-ccB subtype |
3.298400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.540240E-01 |
| Normal-vs-N1 |
8.259000E-01 |
| N0-vs-N1 |
6.117200E-01 |
|
|
